Literature DB >> 26069536

Autologous Matrix-Induced Chondrogenesis (AMIC): Combining Microfracturing and a Collagen I/III Matrix for Articular Cartilage Resurfacing.

J P Benthien1, P Behrens2.   

Abstract

Options for the treatment of cartilage defects include chondral resurfacing with abrasion, debridement, autologous chondrocyte transplantation (ACT), matrix-induced chondrocyte transplantation (MACI), or osteochondral autologous transplantation (OATS). This article describes the new method of autologous matrix-induced chondrogenesis (AMIC), a 1-step procedure combining subchondral microfracture with the fixation of a collagen I/III membrane by a partially autologous fibrin glue. Indications and contraindications are provided; a technical note is given. This method is primarily applied in osteochondral lesions of the knee and ankle joints; other joints may qualify.

Entities:  

Keywords:  AMIC; autologous cartilage repair; microfracturing

Year:  2010        PMID: 26069536      PMCID: PMC4440611          DOI: 10.1177/1947603509360044

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   4.634


Introduction

Among the cartilage resurfacing procedures currently applied are abrasion arthroplasty and debridement. Britberg introduced the autologous chondrocyte transplantation (ACT), which involves a 2-step procedure transplanting chondrocytes previously taken from a donor site into a cartilage defect.[1] Steadman developed the method of microfracturing in the 1990s. The calcified subchondral bone/cartilage border is perforated; consecutively fibrous cartilage is developed from mesenchymal stem cells.[2-4] The matrix-associated chondrogenesis is a further development in cartilage resurfacing, which allows mesenchymal stem cells (MSCs) to develop into chondrocytes with the aid of a collagen scaffold.[5,6] The matrix-induced autologous chondrocyte transplantation (MACI) combines this matrix technology with the ACT. A prospective randomized study by Bartlett et al. yielded similar results in both techniques.[5] As the MACI method is even more expensive than the regular ACT, and both are not reimbursed by many health insurance companies in Europe, a more economic method was searched to perform cost-effective joint resurfacing. The autologous matrix-induced chondrogenesis (AMIC) as first introduced by Behrens[6-9] further develops the scaffold technique in combination with microfracturing. It is a 1-step procedure that involves microfracturing of the debrided cartilage lesion and a commercially available collagen I/III matrix for covering the blood clot and its MSCs. Fixation is with partial autologous fibrin glue in which the thrombin part is yielded from the patient’s serum. Fixation by sutures as performed with the MACI may lead to cartilage damage.[6] This problem may be solved by gluing techniques.[10] It should be noted that commercially available fibrin glue seems to act as an additional scaffold for chondrocytes and that its contents in TGF β are considerable, possibly helping in the differentiation of MSCs.[8] The objective of AMIC is resurfacing of articular cartilage defects to restore a pain-free joint with physiological range of motion. The indications of AMIC are symptomatic full-thickness chondral and subchondral defects in the major joints, maximum size of 1.5 cm[2], posttraumatic or osteochondrosis dissecans, and location in the main weightbearing area of the joint or maximum area of pain. The contraindications of AMIC are inflammatory diseases (e.g., rheumatoid arthritis), tumor, associated fracture, multiple lesions, noncompliant patient, extension deficit of more than 10°, flexion deficit of less than 100°, untreated meniscectomy without meniscal replacement, malalignment, and uncorrected ligament deficiency.

Preoperative Diagnostic Steps

After the patient’s history and physical examination are taken, standard weightbearing anteroposterior and lateral X-rays are performed. A posteroanterior weightbearing notch view of the knee may also be added to the preoperative work-up. If the knee is affected, a full-standing X-ray of both legs is taken to evaluate the axis, and an axial X-ray of the patella is taken. T1- and T2-weighted magnetic resonance imaging scans of the joint are taken to evaluate accompanying injuries and to gain a preoperative status of the cruciate ligaments and the cartilage.

Patient Information

Common surgical risks include postoperative infection, thrombosis, hemorrhage, delayed wound healing, partial weightbearing and limited range of motion for a minimum of 6 weeks, postoperative rehabilitation, alternative procedures, and self-limiting of cartilage lesions. The patient should be aware and agree that an arthrotomy will be performed.

Surgical Technique

The procedure may be performed in spinal or general anesthesia. The patient should be in a supine position. A tourniquet is advised for better views. The procedure starts with an arthroscopy of the affected joint to verify the size and location of the defect and also the amount of accompanying disorder. If the size is located and an AMIC procedure is recommended, a minimally invasive arthrotomy is performed,[11] and the defect is visualized openly (). The defective cartilage tissue and subchondral bone are removed with a curette. Microfracturing is performed with the corresponding microfracturing probes (). The size of the defect is evaluated, and a collagen membrane is measured. It should be slightly undersized to avoid dislocation after movement. An aluminum template may be used to determine the size of the lesion. For preparation of the fibrin glue, several options exist: a partially autologous fibrin glue may be manufactured by centrifuging a blood sample from the patient and mixing the yielded thrombin with allogenic fibrinogen. Completely allogenic fibrin glue as commercially available or suturing for fixation may also be performed. The partially autologous fibrin glue is the authors’ fixation method of choice. Suturing may also be performed but may lead to cartilage damage.[6] Knecht et al. have confirmed that gluing with fibrin glue leads to sufficient stability.[10] It should be kept in mind that according to the original method, the collagen membrane should be placed slightly below the cartilage level to avoid displacement. If the joint is gently moved intraoperatively, inspection of the site usually yields that the membrane remains in place. The membrane is attached to cover the defect ( and ).
Figure 1.

The defect is clearly visible on the medial left femoral condyle. The arthroscopic view (A) demonstrates a grade 4 lesion according to the Outerbridge classification. This is confirmed by a mini open arthrotomy (B). (C) Reproduced with kind permission by Geistlich (Wolhusen, Switzerland).

Figure 2.

(A) After curettage of the lesion, microfracturing may be performed. A blood clot should form. (B) Reproduced with kind permission by Geistlich (Wolhusen, Switzerland).

Figure 3.

(A) The collagen membrane is fixed with partially autologous fibrin glue, which is the original AMIC method. Allogenic fibrin glue may also be applied for fixation. (B) Reproduced with kind permission by Geistlich (Wolhusen, Switzerland).

Figure 4.

(A) The collagen membrane is definitely fixed with partially autologous fibrin glue. (B) Reproduced with kind permission by Geistlich (Wolhusen, Switzerland).

The defect is clearly visible on the medial left femoral condyle. The arthroscopic view (A) demonstrates a grade 4 lesion according to the Outerbridge classification. This is confirmed by a mini open arthrotomy (B). (C) Reproduced with kind permission by Geistlich (Wolhusen, Switzerland). (A) After curettage of the lesion, microfracturing may be performed. A blood clot should form. (B) Reproduced with kind permission by Geistlich (Wolhusen, Switzerland). (A) The collagen membrane is fixed with partially autologous fibrin glue, which is the original AMIC method. Allogenic fibrin glue may also be applied for fixation. (B) Reproduced with kind permission by Geistlich (Wolhusen, Switzerland). (A) The collagen membrane is definitely fixed with partially autologous fibrin glue. (B) Reproduced with kind permission by Geistlich (Wolhusen, Switzerland). The postoperative management is as follows: maximum weightbearing of 15 to 20 kg for 6 weeks, and common thrombose prophylaxis with a low molecular heparine. Removal of a possible drain 24 hours after surgery is recommended. Care should be exercised while the suction is removed, as membrane dislocation could result. Maximum flexion of the knee should not exceed 30° for 2 weeks following the operation. Assisted active physical therapy may be applied, minding the weight and range of motion limits. Isometric quadriceps training, straight length raising, and hamstring isometrics are possible. Flexion is raised to 60° and 90° for another 2 weeks, respectively. The patient is seen in the outpatient clinic 6 weeks after the appointment. Postoperative physical therapy should focus on muscle strengthening exercises as well as progressively increased joint mobilization. After 6 weeks, progressive exercising is possible with light biking in a slight resistance setting. Combining microfracturing with a collagen I/III scaffold may be a cost-effective option to resurface cartilage defects. Prospective studies should compare the results of the AMIC procedure as compared to microfracturing alone and MACI.
  11 in total

1.  Migration pattern, morphology and viability of cells suspended in or sealed with fibrin glue: a histomorphologic study.

Authors:  J Gille; U Meisner; E M Ehlers; A Müller; M Russlies; P Behrens
Journal:  Tissue Cell       Date:  2005-10       Impact factor: 2.466

2.  Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI)--5-year follow-up.

Authors:  Peter Behrens; Thomas Bitter; Bodo Kurz; Martin Russlies
Journal:  Knee       Date:  2006-04-24       Impact factor: 2.199

3.  The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study.

Authors:  Kai Mithoefer; Riley J Williams; Russell F Warren; Hollis G Potter; Christopher R Spock; Edward C Jones; Thomas L Wickiewicz; Robert G Marx
Journal:  J Bone Joint Surg Am       Date:  2005-09       Impact factor: 5.284

4.  Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study.

Authors:  W Bartlett; J A Skinner; C R Gooding; R W J Carrington; A M Flanagan; T W R Briggs; G Bentley
Journal:  J Bone Joint Surg Br       Date:  2005-05

5.  Mechanical testing of fixation techniques for scaffold-based tissue-engineered grafts.

Authors:  Sven Knecht; Christoph Erggelet; Michaela Endres; Michael Sittinger; Christian Kaps; Edgar Stüssi
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2007-10       Impact factor: 3.368

Review 6.  Microfracture: surgical technique and rehabilitation to treat chondral defects.

Authors:  J R Steadman; W G Rodkey; J J Rodrigo
Journal:  Clin Orthop Relat Res       Date:  2001-10       Impact factor: 4.176

7.  Apoptotic chondrocyte death in cell-matrix biocomposites used in autologous chondrocyte transplantation.

Authors:  Justus Gille; Eva-M Ehlers; Mathias Okroi; Martin Russlies; Peter Behrens
Journal:  Ann Anat       Date:  2002-07       Impact factor: 2.698

Review 8.  Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up.

Authors:  J Richard Steadman; Karen K Briggs; Juan J Rodrigo; Mininder S Kocher; Thomas J Gill; William G Rodkey
Journal:  Arthroscopy       Date:  2003 May-Jun       Impact factor: 4.772

9.  In vivo matrix-guided human mesenchymal stem cells.

Authors:  J Kramer; F Böhrnsen; U Lindner; P Behrens; P Schlenke; J Rohwedel
Journal:  Cell Mol Life Sci       Date:  2006-03       Impact factor: 9.261

10.  Autologous chondrocyte implantation--technique and long-term follow-up.

Authors:  Mats Brittberg
Journal:  Injury       Date:  2008-04       Impact factor: 2.586

View more
  31 in total

1.  Autologous matrix-induced chondrogenesis combined with platelet-rich plasma gel: technical description and a five pilot patients report.

Authors:  A A M Dhollander; F De Neve; K F Almqvist; R Verdonk; S Lambrecht; D Elewaut; G Verbruggen; P C M Verdonk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-12-11       Impact factor: 4.342

2.  Five-year results of arthroscopic techniques for the treatment of acetabular chondral lesions in femoroacetabular impingement.

Authors:  Donato Mancini; Andrea Fontana
Journal:  Int Orthop       Date:  2014-06-21       Impact factor: 3.075

Review 3.  Intraoperative stem cell therapy.

Authors:  Mónica Beato Coelho; Joaquim M S Cabral; Jeffrey M Karp
Journal:  Annu Rev Biomed Eng       Date:  2012       Impact factor: 9.590

4.  Autologous Membrane Induced Chondrogenesis (AMIC) for the treatment of acetabular chondral defect.

Authors:  Andrea Fontana
Journal:  Muscles Ligaments Tendons J       Date:  2016-12-21

5.  Arthroscopic technique for the treatment of patellar chondral lesions with the patient in the supine position.

Authors:  Ricardo Cuéllar; Adrián Cuéllar; Juan Ponte; Miguel A Ruiz-Ibán
Journal:  Arthrosc Tech       Date:  2014-06-02

Review 6.  Single-step scaffold-based cartilage repair in the knee: A systematic review.

Authors:  Stefan Fischer; Agnes Kisser
Journal:  J Orthop       Date:  2016-06-25

7.  The Use of All-Arthroscopic Autologous Matrix-Induced Chondrogenesis for the Management of Humeral and Glenoid Chondral Defects in the Shoulder.

Authors:  Adrián Cuéllar; Miguel Ángel Ruiz-Ibán; Ricardo Cuéllar
Journal:  Arthrosc Tech       Date:  2016-03-07

8.  Micrometer scale guidance of mesenchymal stem cells to form structurally oriented large-scale tissue engineered cartilage.

Authors:  Chih-Ling Chou; Alexander L Rivera; Valencia Williams; Jean F Welter; Joseph M Mansour; Judith A Drazba; Takao Sakai; Harihara Baskaran
Journal:  Acta Biomater       Date:  2017-07-11       Impact factor: 8.947

9.  A Systematic Review and Guide to Mechanical Testing for Articular Cartilage Tissue Engineering.

Authors:  Jay M Patel; Brian C Wise; Edward D Bonnevie; Robert L Mauck
Journal:  Tissue Eng Part C Methods       Date:  2019-09-30       Impact factor: 3.056

10.  Arthroscopic Treatment of Chondral and Osteochondral Defects in the Ankle Using the Autologous Matrix-Induced Chondrogenesis Technique.

Authors:  Tomasz Piontek; Paweł Bąkowski; Kinga Ciemniewska-Gorzela; Jakub Naczk
Journal:  Arthrosc Tech       Date:  2015-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.